CML is associated with the fusion of the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9, resulting in the BCR::ABL1 fusion gene, which encodes a non‐receptor tyrosine kinase that becomes deregulated and constitutively active. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.